Portable point-of-care wound imaging system to detect elevated bacterial loads in wounds – and become the standard of care for wound care diagnostics

Moleculight has developed and commercialized a portable point-of-care wound imaging system – with models called the MolecuLight i:X® and DX™ — to detect elevated bacterial loads in wounds and to perform digital measurement of wounds. The devices are FDA/CE/Health Canada approved, have a robust reimbursement pathway in the USA and Korea and have over 60 peer-reviewed publications, including 1,500+ patients, to provide a comprehensive body of clinical evidence supporting the utility of the devices for improving wound care decision-making and patient outcomes. With a direct sales channel in North America and 16 distributors in 18 global markets, MolecuLight is successful on route to become the standard of care for wound care diagnostics.